Department of Dermatology, University of Florida College of Medicine, Gainesville, FlL.
Dermatol Online J. 2021 Mar 15;27(3):13030/qt8t1502zt.
Reactive angioendotheliomatosis (RAE) is an uncommon, benign, antiproliferative condition associated with systemic diseases that may cause occlusion or inflammation of the vascular lumina. A link between antiphospholipid syndrome (APS) and RAE has been reported a few times in the literature. Herein, we present a unique case of RAE diagnosed in a patient with primary APS who was well-managed on warfarin and rituximab with no recent thrombotic events. As RAE can precede or follow a diagnosis of APS, the presence of the condition indicates a need to workup for APS and to ensure those with the condition are adequately anticoagulated. However, as demonstrated in this case, the condition can still occur in patients who are adequately anticoagulated.
反应性血管内皮细胞瘤(RAE)是一种罕见的良性抗增殖性疾病,与可能导致血管腔闭塞或炎症的系统性疾病有关。文献中曾多次报道抗磷脂综合征(APS)与 RAE 之间存在关联。在此,我们报告了一例原发性 APS 患者中诊断出的 RAE 独特病例,该患者用华法林和利妥昔单抗治疗效果良好,且近期无血栓事件。由于 RAE 可先于或后于 APS 诊断,因此该疾病的存在表明需要进行 APS 检查,并确保患有该疾病的患者得到充分抗凝。然而,正如本例所示,在充分抗凝的患者中仍可能发生这种疾病。